Jin Han
Center Affiliate, Center for Pharmacoepidemiology and Pharmacoeconomic Research
Clinical Associate Professor, University of Illinois at Chicago
Contact
Address:
833 S. Wood Street Rm 164 (MC886), Chicago, IL
Office Phone:
Email:
Related Sites:
About Heading link
Research Interests:
Pain management, sickle cell disease (SCD), safety and effectiveness of agents used in SCD, evaluation of clinical pharmacy services and interventions, and pharmacogenomics.
Teaching and Supervision Heading link
Clinical Applications (PHAR 520), 8/22/2022 – 12/2/2022
Clinical Applications (PHAR 520), 8/22/2022 – 12/2/2022
Clinical Applications (PHAR 520), 8/22/2022 – 12/2/2022
Clinical Applications (PHAR 520), 8/22/2022 – 12/2/2022
PDAT 9: Hematology/Oncology (PHAR 509), 1/1/2022 – 4/30/2022
PDAT 9: Hematology/Oncology (PHAR 509), 1/1/2022 – 4/30/2022
Pharmacokinetics (PHAR 435), 8/29/2021 – 12/31/2021
Clinical Applications (PHAR 520), 8/23/2021 – 12/3/2021
Clinical Applications (PHAR 520), 8/23/2021 – 12/3/2021
Selected Grants
Sickle Treatment and Outcomes Research in the Midwest (STORM), Cincinnati Childrens Hospital Medical Center., 9/1/2021 - 8/31/2023, Obligated Amount: $110000; Anticipated Amount: $110000
Platelet Decline as a Predictor of Complications in Sickle Cell Disease Sickle cell disease, Takeda Pharmaceuticals., 3/3/2021 - 8/31/2022, Obligated Amount: $216729.81; Anticipated Amount: $216729.81
The Efficacy and Safety of Ferriprox® for the Treatment of Transfusional Iron Overload in Patients with Sickle Cell Disease or Other Anemias, ApoPharma., 12/12/2014 - 10/1/2015, No Obligated Amount Set; No Anticipated Amount Set
Selected Publications
Njoku, F, Zhang, X, Shah, BN, Han, J, Machado, R, Saraf, SL, Gordeuk, VR. (2023). Associations of hemolysis and anemia with cardiopulmonary dysfunction in an adult sickle cell disease cohort. Clinica Chimica Acta, 540. doi:10.1016/j.cca.2023.117223.
Han, Jin, Zhang, Xu, Molokie, Robert E, Njoku, Franklin, Hussain, Faiz Ahmed, Farooqui, Marwah, Rizvi, Insia, Saraf, Santosh L, Gordeuk, Victor R. (2022). COVID-19 Vaccination Status and Disease Burden in Patients with Sickle Cell Disease. Blood, 140, (Supplement 1), 5027-5028. doi:10.1182/blood-2022-166597.
Han, J, Zhang, X, Molokie, RE, Njoku, FU, Hussain, FA, Farooqui, M, Rizvi, I, Saraf, SL, Gordeuk, VR. (2022). COVID-19 vaccination status and disease burden in patients with sickle cell disease. British Journal of Haematology, 199, (4), e21-e24. doi:10.1111/bjh.18443.
Han, J, Molokie, RE, Hussain, F, Njoku, F, Gordeuk, VR, Saraf, SL. (2022). Voxelotor and albuminuria in adults with sickle cell anaemia. British Journal of Haematology, 197, (5), e63-e64. doi:10.1111/bjh.18076.
Han, J, Saraf, SL, Gowhari, M, Hussain, FA, Jain, S, Kavoliunaite, L, Molokie, RE, Gordeuk, VR. (2022). Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease. Annals of Pharmacotherapy, 56, (2), 222-223. doi:10.1177/10600280211024524.
Zolekar, A, Kim, K, Lee, JC, Han, J, Duarte, JD, Galanter, WL, Cavallari, LH, Nutescu, EA. (2022). Changing from mandatory to optional genotyping results in higher acceptance of pharmacist-guided warfarin dosing. Pharmacogenomics, 23, (2), 85-95. doi:10.2217/pgs-2021-0109.
Han, Jin, Srisuwananukorn, Andrew, Shah, Binal N, Molokie, Robert E, Lash, James P, Gordeuk, Victor R, Saraf, Santosh L. (2021). Effects of renin‐angiotensin blockade and APOL1 on kidney function in sickle cell disease. eJHaem, 2, (3), 483-484. doi:10.1002/jha2.259.
Njoku, F, Zhang, X, Shah, BN, Machado, RF, Han, J, Saraf, SL, Gordeuk, VR. (2021). Biomarkers of clinical severity in treated and untreated sickle cell disease: a comparison by genotypes of a single center cohort and African Americans in the NHANES study. British Journal of Haematology, 194, (4), 767-778. doi:10.1111/bjh.17682.
Srisuwananukorn, A, Han, J, Raslan, R, Gowhari, M, Hussain, F, Njoku, F, Molokie, RE, Gordeuk, VR, Saraf, SL. (2021). Antimicrobial resistance is a risk factor for mortality in adults with sickle cell disease. Haematologica, 106, (6), 1745-1748. doi:10.3324/haematol.2020.267872.
Professional Leadership
ACCP 2023 Annual Meeting Program Committee, 10/15/2021 - Present
Education
Degrees:
PharmD, University of Illinois at Chicago, United States
PhD, Baylor College of Medicine, Texas
BS, Peking University, China
Postgraduate Training:
PGY1 Pharmacy Resident, Rush University Medical Center, United States
Howard Hughes Medical Institute Postdoctoral Fellow, University of Chicago, United States
Licensures and Certifications
Registered Pharmacist, State of Illinois, Date Not Set - Present
Pharmacotherapy Specialist, Board of Pharmacy Specialties, Date Not Set - Present
Selected Presentations
Han, Jin, Kevin, Wake, Emily, Tsiao. (2022 March 30). A Managed Care Approach to Racial Health Disparities in Sickle Cell Disease. AMCP Annual Meeting. Chicago, US.
Han, Jin. (2021 October 22). Medication accessibility in managing a rare disease, sickle cell anemia. The Forbidden City International Pharmacist Forum. Virtual.
Han, Jin. (2021 October 22). New treatment options in sickle cell disease. Missouri Pharmacist Association Annual Conference. St Louis.